|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Memorial Sloan-Kettering Cancer Center National Institutes of Health (NIH) National Cancer Institute (NCI) Virginia Commonwealth University |
|---|---|
| Information provided by: | Memorial Sloan-Kettering Cancer Center |
| ClinicalTrials.gov Identifier: | NCT00662324 |
Purpose
The purpose of this study is to develop a Question Prompt List (QPL) about clinical trials for cancer patients and find out what cancer patients and their caregivers think of the QPL. A QPL is a list of questions patients might want to ask their doctors during their appointments.
We will conduct three focus groups to talk about using QPL's as a new way to recruit patients like you to clinical trials. The three groups will be made of patients who have and have not participated in clinical trials, their caregivers and doctors. This study is also being done to learn about how the QPL affects the question asking behavior of patients during their appointments with doctors at Memorial SloanKettering Cancer Center (MSKCC).
| Condition | Intervention |
|---|---|
|
Breast Cancer Lung Cancer Prostate Cancer |
Behavioral: focus groups |
| Study Type: | Observational |
| Study Design: | Cohort, Prospective |
| Official Title: | Development of a Clinical Trial Specific Question Prompt List |
| Estimated Enrollment: | 126 |
| Study Start Date: | April 2008 |
| Estimated Study Completion Date: | April 2010 |
| Estimated Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
1
Trial experienced cancer patients and their primary caregivers.
|
Behavioral: focus groups
Focus group with MSKCC patients with lung, breast and prostate cancer who have taken part in clinical trials and other caregivers. This focus group will be audio recorded. During the focus group, you will discuss a Question Prompt List that will be handed out to you. You will be asked about what you think of it and if you think it would have been useful to the patient you care for in his/her experience in a clinical trial. The focus group to last from 60 to 90 minutes. |
|
2
Trial naive cancer patients and their caregivers.
|
Behavioral: focus groups
Focus group with MSKCC patients with lung, breast and prostate cancer who have not taken part in clinical trials and other caregivers. This focus group will be audio recorded. During the focus group, you will discuss a Question Prompt List that will be handed out to you. You will be asked about what you think of it and if you think it would be useful if the patient you care for were ever to take part in a clinical trial sometime in the future. We expect the focus group to last from 60 to 90 minutes. |
|
3
Health care professionals who are involved in running Phase I, II or III clinical trials.
|
Behavioral: focus groups
MSKCC clinicians who work with lung, breast and prostate cancer patients. This focus group will be audio recorded. During the focus group, you will discuss a Question Prompt List that will be handed out to you. You will be asked about what you think of it and if you think it would be useful to your patients who take part in clinical trials. Expect the focus group to last from 60 to 90 minutes. |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
treatment at MSKCC of lung, prostate or breast cancer A current health care professional at MSKCC current involvement in recruiting patients with lung, prostate or breast cancer to Phase I,II, or III clinical trials at MSKCC
Inclusion Criteria:
Patient caregiver eligibility requirements will be:
Population Segment 2 who have not participated in a clinical trial:
Patient caregiver eligibility requirements will be:
Population Segment 3 who are health care professionals:
Exclusion Criteria:
Potential subjects will be considered ineligible for either/both phases of this study if they are:
Contacts and Locations| Contact: Carma Bylund, PhD | bylundlc@mskcc.org | |
| Contact: Jamie Ostroff, PhD | ostroffj@mskcc.org |
| United States, New York | |
| Memorial Sloan-Kettering Cancer Center | Recruiting |
| New York, New York, United States, 10065 | |
| Contact: Carma Bylund, PhD bylundlc@mskcc.org | |
| Contact: Jamie Ostroff, PhD ostroffj@mskcc.org | |
| Principal Investigator: Carma Bylund, PhD | |
| Principal Investigator: | Carmen Bylund, PhD | Memorial Sloan-Kettering Cancer Center |
More Information
| Responsible Party: | Memorial Sloan-Kettering Cancer Center ( Carma Bylund, Ph.D. ) |
| Study ID Numbers: | 08-042, NIH/NCI R03 CA130598-01 |
| Study First Received: | April 17, 2008 |
| Last Updated: | April 27, 2009 |
| ClinicalTrials.gov Identifier: | NCT00662324 History of Changes |
| Health Authority: | United States: Institutional Review Board |
|
Thoracic Neoplasms Prostatic Diseases Genital Neoplasms, Male Respiratory Tract Diseases Skin Diseases Lung Neoplasms |
Lung Diseases Breast Neoplasms Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms Breast Diseases |
|
Thoracic Neoplasms Respiratory Tract Neoplasms Prostatic Diseases Skin Diseases Genital Neoplasms, Male Breast Neoplasms Urogenital Neoplasms Genital Diseases, Male |
Neoplasms Neoplasms by Site Respiratory Tract Diseases Lung Neoplasms Lung Diseases Prostatic Neoplasms Breast Diseases |
